Navigation Links
Biomarker May Signal HIV Progression
Date:3/28/2008

Increase in specific white blood cells could warn doctors early to change treatments

FRIDAY, March 28 (HealthDay News) -- Researchers at Temple University think they may have found a blood marker that denotes the progression of the virus that causes AIDS.

The researchers found an increase in the CD163+/CD16+ monocyte subset may coincide with the advancement of human immunodeficiency virus (HIV), according to a study published in the March issue of AIDS Research and Human Retroviruses.

"It looks like, based on these correlations, that this particular cell type may be involved in immune impairment and the progression of HIV," Jay Rappaport, a professor of neuroscience and neurovirology who oversaw the study, said in a prepared statement. "Is it a good prognostic indicator? If you have a lot of these monocytes, does it mean you are going to progress into AIDS faster? Right now, all we know is what the correlations are."

A monocyte is a specific white blood cell, a part of the human body's immune system that protects against blood-borne pathogens and moves quickly to sites of infection within the body's tissues. As monocytes enter tissue, they undergo a series of changes.

The researchers investigated these alterations by examining 18 patients with HIV and seven individuals without HIV.

"We did, indeed, find that patients with detectable virus had an increase of this monocyte subset that correlated with the amount of virus they had in their blood," study author Tracy Fischer-Smith, an associate scientist in Temple's Neuroscience Department, said in a prepared statement. "We were surprised to find that in patients with CD4+ T-cell counts of less than 450 cells per microliter [200 or less per microliter is defined as AIDS], the increase of this monocyte subset correlates inversely with the number of T-cells."

Fischer-Smith said this finding suggests that as the monocyte cells are increasing, these patients are losing CD4+ T-cells, which are critical for maintaining one's immune system.

"This may actually provide an earlier window into what is happening with HIV-infected patients where we might be able to see that immune impairment is taking place before we see a dramatic loss of CD4+ T-cells," she said.

The researchers plan to expand this study by following a cohort of patients over time to see if their findings can provide doctors with an early warning system and help them design better therapeutic strategies, Fischer-Smith said.

More information

The U.S. Department of Health and Human Services has more about HIV and AIDS.



-- Kevin McKeever



SOURCE: Temple University, news release, March 28, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Expansion of monocyte subset could serve as a biomarker for HIV progressions
2. Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
3. Biomarkers for Mood May Alter Psychiatric Treatments
4. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
5. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
6. New developments in biomarkers for epithelial ovarian cancer
7. Biomarkers for Alzheimers disease can be trusted in clinical trials
8. JDRF and Lilly partner to fund research to identify beta cell biomarkers
9. Biomarkers predict risk for invasive breast cancer years before the tumor develops
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Biomarker may be an early predictor of advanced breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... On Tuesday, April 26, 2016 members of the HomeTown ... of Gov. Nathan Deal on SB 258, the “Rural Health Care Relief” Bill. , ... 70% tax credit to individuals and corporations which donate directly to a “rural hospital” ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for ... Island Park on Sunday, with sunny skies, a light breeze and temperatures in the ... , The 5k Run and Walk and 1-mile walk were held to ...
(Date:4/29/2016)... ... 2016 , ... The Wharton School of the University ... of the 2016 Wharton Business Plan Competition —as well as the Wharton ... the Committee Award for Most ‘Wow Factor,’ making them the first team in ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
(Date:4/29/2016)... ... April 29, 2016 , ... For those who skip ... meal to miss. That was among the many new lifestyle diet tips offered by ... Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence noted that because ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... H1 2016" market research report that provides an ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
Breaking Medicine Technology: